Report Detail
Global Neuropeptide Y Receptor Market Insights, Forecast to 2025
- RnM2344684 |
- 04 June, 2019 |
- Global |
- 112 Pages |
- QYResearch |
- Pharma & Healthcare
Neuropeptide Y (NPY) receptors are involved in different types of biological processes. It is a class of G-Protein coupled receptors sensitive to closely associated peptide hormones such as peptide YY, pancreatic polypeptide, and neuropeptide Y. NPY is closely related to central mechanism involving obesity and food intake; however the topic is still a part of extensive medical research.
Increase in prevalence of various diseases related to obesity and surge in overweight populace drives the market.
Moreover, unhealthy urban lifestyle and increase in number of fast food eating populace susceptible to sudden weight gain, is expected to boost the market growth.
However, number of limited manufacturers and distribution channels is anticipated to impede the market growth.
The global Neuropeptide Y Receptor market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Neuropeptide Y Receptor market based on company, product type, end user and key regions.
This report studies the global market size of Neuropeptide Y Receptor in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Neuropeptide Y Receptor in these regions.
This research report categorizes the global Neuropeptide Y Receptor market by top players/brands, region, type and end user. This report also studies the global Neuropeptide Y Receptor market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Gila Therapeutics
Novo Nordisk
XL-protein
Lilly Eli
Novartis
Pfizer
Merck & Co
Mannkind
Gilead Sciences
Genentech
Market size by Product
Food Grade
Pharmaceutical Grade
Market size by End User
Medicine
Food Additives
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Neuropeptide Y Receptor market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Neuropeptide Y Receptor market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Neuropeptide Y Receptor companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Neuropeptide Y Receptor submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Neuropeptide Y Receptor are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Neuropeptide Y Receptor market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Neuropeptide Y Receptor Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Neuropeptide Y Receptor Market Size Growth Rate by Product
- 1.4.2 Food Grade
- 1.4.3 Pharmaceutical Grade
- 1.5 Market by End User
- 1.5.1 Global Neuropeptide Y Receptor Market Size Growth Rate by End User
- 1.5.2 Medicine
- 1.5.3 Food Additives
- 1.5.4 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Neuropeptide Y Receptor Market Size
- 2.1.1 Global Neuropeptide Y Receptor Revenue 2014-2025
- 2.1.2 Global Neuropeptide Y Receptor Sales 2014-2025
- 2.2 Neuropeptide Y Receptor Growth Rate by Regions
- 2.2.1 Global Neuropeptide Y Receptor Sales by Regions
- 2.2.2 Global Neuropeptide Y Receptor Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Neuropeptide Y Receptor Sales by Manufacturers
- 3.1.1 Neuropeptide Y Receptor Sales by Manufacturers
- 3.1.2 Neuropeptide Y Receptor Sales Market Share by Manufacturers
- 3.1.3 Global Neuropeptide Y Receptor Market Concentration Ratio (CR5 and HHI)
- 3.2 Neuropeptide Y Receptor Revenue by Manufacturers
- 3.2.1 Neuropeptide Y Receptor Revenue by Manufacturers (2014-2019)
- 3.2.2 Neuropeptide Y Receptor Revenue Share by Manufacturers (2014-2019)
- 3.3 Neuropeptide Y Receptor Price by Manufacturers
- 3.4 Neuropeptide Y Receptor Manufacturing Base Distribution, Product Types
- 3.4.1 Neuropeptide Y Receptor Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Neuropeptide Y Receptor Product Type
- 3.4.3 Date of International Manufacturers Enter into Neuropeptide Y Receptor Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Neuropeptide Y Receptor Sales by Product
- 4.2 Global Neuropeptide Y Receptor Revenue by Product
- 4.3 Neuropeptide Y Receptor Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Neuropeptide Y Receptor Breakdown Data by End User
6 North America
- 6.1 North America Neuropeptide Y Receptor by Countries
- 6.1.1 North America Neuropeptide Y Receptor Sales by Countries
- 6.1.2 North America Neuropeptide Y Receptor Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Neuropeptide Y Receptor by Product
- 6.3 North America Neuropeptide Y Receptor by End User
7 Europe
- 7.1 Europe Neuropeptide Y Receptor by Countries
- 7.1.1 Europe Neuropeptide Y Receptor Sales by Countries
- 7.1.2 Europe Neuropeptide Y Receptor Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Neuropeptide Y Receptor by Product
- 7.3 Europe Neuropeptide Y Receptor by End User
8 Asia Pacific
- 8.1 Asia Pacific Neuropeptide Y Receptor by Countries
- 8.1.1 Asia Pacific Neuropeptide Y Receptor Sales by Countries
- 8.1.2 Asia Pacific Neuropeptide Y Receptor Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Neuropeptide Y Receptor by Product
- 8.3 Asia Pacific Neuropeptide Y Receptor by End User
9 Central & South America
- 9.1 Central & South America Neuropeptide Y Receptor by Countries
- 9.1.1 Central & South America Neuropeptide Y Receptor Sales by Countries
- 9.1.2 Central & South America Neuropeptide Y Receptor Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Neuropeptide Y Receptor by Product
- 9.3 Central & South America Neuropeptide Y Receptor by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Neuropeptide Y Receptor by Countries
- 10.1.1 Middle East and Africa Neuropeptide Y Receptor Sales by Countries
- 10.1.2 Middle East and Africa Neuropeptide Y Receptor Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Neuropeptide Y Receptor by Product
- 10.3 Middle East and Africa Neuropeptide Y Receptor by End User
11 Company Profiles
- 11.1 Gila Therapeutics
- 11.1.1 Gila Therapeutics Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Gila Therapeutics Neuropeptide Y Receptor Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Gila Therapeutics Neuropeptide Y Receptor Products Offered
- 11.1.5 Gila Therapeutics Recent Development
- 11.2 Novo Nordisk
- 11.2.1 Novo Nordisk Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Novo Nordisk Neuropeptide Y Receptor Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Novo Nordisk Neuropeptide Y Receptor Products Offered
- 11.2.5 Novo Nordisk Recent Development
- 11.3 XL-protein
- 11.3.1 XL-protein Company Details
- 11.3.2 Company Business Overview
- 11.3.3 XL-protein Neuropeptide Y Receptor Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 XL-protein Neuropeptide Y Receptor Products Offered
- 11.3.5 XL-protein Recent Development
- 11.4 Lilly Eli
- 11.4.1 Lilly Eli Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Lilly Eli Neuropeptide Y Receptor Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Lilly Eli Neuropeptide Y Receptor Products Offered
- 11.4.5 Lilly Eli Recent Development
- 11.5 Novartis
- 11.5.1 Novartis Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Novartis Neuropeptide Y Receptor Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Novartis Neuropeptide Y Receptor Products Offered
- 11.5.5 Novartis Recent Development
- 11.6 Pfizer
- 11.6.1 Pfizer Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Pfizer Neuropeptide Y Receptor Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Pfizer Neuropeptide Y Receptor Products Offered
- 11.6.5 Pfizer Recent Development
- 11.7 Merck & Co
- 11.7.1 Merck & Co Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Merck & Co Neuropeptide Y Receptor Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Merck & Co Neuropeptide Y Receptor Products Offered
- 11.7.5 Merck & Co Recent Development
- 11.8 Mannkind
- 11.8.1 Mannkind Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Mannkind Neuropeptide Y Receptor Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Mannkind Neuropeptide Y Receptor Products Offered
- 11.8.5 Mannkind Recent Development
- 11.9 Gilead Sciences
- 11.9.1 Gilead Sciences Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Gilead Sciences Neuropeptide Y Receptor Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Gilead Sciences Neuropeptide Y Receptor Products Offered
- 11.9.5 Gilead Sciences Recent Development
- 11.10 Genentech
- 11.10.1 Genentech Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Genentech Neuropeptide Y Receptor Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Genentech Neuropeptide Y Receptor Products Offered
- 11.10.5 Genentech Recent Development
12 Future Forecast
- 12.1 Neuropeptide Y Receptor Market Forecast by Regions
- 12.1.1 Global Neuropeptide Y Receptor Sales Forecast by Regions 2019-2025
- 12.1.2 Global Neuropeptide Y Receptor Revenue Forecast by Regions 2019-2025
- 12.2 Neuropeptide Y Receptor Market Forecast by Product
- 12.2.1 Global Neuropeptide Y Receptor Sales Forecast by Product 2019-2025
- 12.2.2 Global Neuropeptide Y Receptor Revenue Forecast by Product 2019-2025
- 12.3 Neuropeptide Y Receptor Market Forecast by End User
- 12.4 North America Neuropeptide Y Receptor Forecast
- 12.5 Europe Neuropeptide Y Receptor Forecast
- 12.6 Asia Pacific Neuropeptide Y Receptor Forecast
- 12.7 Central & South America Neuropeptide Y Receptor Forecast
- 12.8 Middle East and Africa Neuropeptide Y Receptor Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Neuropeptide Y Receptor Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Neuropeptide Y Receptor . Industry analysis & Market Report on Neuropeptide Y Receptor is a syndicated market report, published as Global Neuropeptide Y Receptor Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Neuropeptide Y Receptor market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
